Loading
No description yet: the sentence for this tag has not been written. 13 records carry it: 13 drugs.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
BEVAC hepatitis B vaccine (Biological E) BEVAC Biological E's hepatitis B vaccine from India, prequalified by WHO in January 2025 in adult and paediatric presentations. | Approved🇮🇳 | none | hepatitis-b-vaccine | ||
Cecolin (bivalent HPV vaccine, Xiamen Innovax) Cecolin A bivalent HPV vaccine made in China by Xiamen Innovax, prequalified by WHO in October 2021, the earlier of the two Chinese HPV vaccines on WHO's list. | Approved🇨🇳 | none | hpv-vaccine | ||
Cecolin 9 (nine-valent HPV vaccine made in E. coli) Cecolin 9 A nine-valent HPV vaccine produced in E. coli bacteria, authorised in China in May 2025; three years after vaccination, antibody levels in young women were no lower than with Gardasil 9. | Approved2025🇨🇳 | none | hpv-vaccine | ||
Engerix-B (hepatitis B vaccine, recombinant) Engerix-B GSK's hepatitis B vaccine, licensed in the United States since 1989 and prequalified by WHO for use in national programmes. | Approved | none | hepatitis-b-vaccine | ||
Euvax B (hepatitis B vaccine, LG Chem) Euvax B LG Chem's hepatitis B vaccine from South Korea, prequalified by WHO since 1996 and available to national immunisation programmes through UN procurement. | Established | none | hepatitis-b-vaccine | ||
Fendrix (hepatitis B vaccine, adjuvanted, for kidney failure) Fendrix GSK's adjuvanted hepatitis B vaccine for people from 15 years of age whose kidneys are failing, including people on dialysis, authorised in the European Union since 2005. | Approved | none | hepatitis-b-vaccine | ||
Heberbiovac HB (hepatitis B vaccine, Cuba) Heberbiovac HB Cuba's hepatitis B vaccine from the Centro de Ingenieria Genetica y Biotecnologia, prequalified by WHO since 2001. | Established | none | hepatitis-b-vaccine | ||
Hepatitis B Vaccine (rDNA), Serum Institute of India Hepatitis B Vaccine (rDNA) The Serum Institute of India's hepatitis B vaccine, prequalified by WHO since 2004 in adult and paediatric presentations. | Approved🇮🇳 | none | hepatitis-b-vaccine | ||
Heplisav-B (hepatitis B vaccine, recombinant, adjuvanted) Heplisav-B Dynavax's adjuvanted hepatitis B vaccine for adults, licensed in the United States in 2017 and in the European Union in 2021. | Approved | none | hepatitis-b-vaccine | ||
PreHevbrio / PreHevbri (hepatitis B vaccine, adults, withdrawn) PreHevbrio VBI Vaccines' adult hepatitis B vaccine, licensed in the United States in 2021 and the European Union in 2022, and no longer marketed in either. | Withdrawn | none | hepatitis-b-vaccine | ||
Recombivax HB / HBVaxPro (hepatitis B vaccine, recombinant) Recombivax HB Merck's hepatitis B vaccine, sold as Recombivax HB in the United States since 1986 and as HBVaxPro in the European Union since 2001. | Approved | none | hepatitis-b-vaccine | ||
Twinrix / Ambirix (combined hepatitis A and B vaccine) Twinrix GSK's combined vaccine against hepatitis A and hepatitis B, licensed in the European Union since 1996 and the United States since 2001; the hepatitis B part is what protects against liver cancer. | Approved | none | hepatitis-b-vaccine | ||
Walrinvax (bivalent HPV vaccine, Yuxi Zerun) Walrinvax A bivalent HPV vaccine made in China by Yuxi Zerun Biotechnology, prequalified by WHO in August 2024. | Approved🇨🇳 | none | hpv-vaccine |